In aggregate, these data highlight the pivotal role of IL-11 in facilitating prostate cancer cell proliferation and tumour growth and underscore the therapeutic potential of targeting IL-11 in conjunction with established chemotherapy regimens. This evidence concerns the gene IL11 and prostate carcinoma.